Nanotechnology Now







Heifer International

Wikipedia Affiliate Button


DHgate

Home > Press > Dr. R. Rox Anderson Joins Medical Advisory Board of Apogee Technology

Abstract:
Apogee Technology, Inc. (AMEX: ATA), an emerging micro-systems and nanotechnology company that designs, develops and commercializes medical devices and sensor products, reported today that Dr. R. Rox Anderson has agreed to join the Company's Medical Advisory Board. Dr. Anderson practices dermatology at Massachusetts General Hospital and is the Director of the Wellman Center for Photomedicine at Massachusetts General Hospital. In addition, Dr. Anderson is a Professor of Dermatology at Harvard Medical School and is an affiliated faculty member at the Massachusetts Institute of Technology (MIT).

Dr. R. Rox Anderson Joins Medical Advisory Board of Apogee Technology

NORWOOD, MA | Posted on March 22nd, 2007

Herbert Stein, Apogee's Chairman and Chief Executive Officer, said, "We are extremely excited to have a leading dermatologist supporting the development of our PyraDerm™ intradermal drug delivery platform. His expertise in the structure of the skin, the treatment of skin diseases and his medical technology development experience will be invaluable as we work towards the commercialization of our delivery solutions for FDA regulated and non regulated applications."

Dr. Anderson has conceived and developed dermatologic surgery using selectively absorbed laser pulses, which is now the preferred basis for treatment of birthmarks, pigmented lesions, tattoos, hypertrichosis and other conditions. He has made many contributions to the understanding and development of laser-tissue interactions, tissue optics, photodynamic therapy, and optical diagnostics. Dr. Anderson received his undergraduate degree from MIT and his M.D. from Harvard Medical School.

####

About Apogee Technology, Inc.
Apogee Technology designs, develops and commercializes proprietary medical device and sensor products using its MEMS and nanotechnology for the medical, automotive, industrial and consumer markets. The Company is developing its PyraDerm™ solution for enhanced intradermal drug delivery and has introduced a family of pressure sensors under the Sensilica® brand. Apogee's goal is to provide value-added and cost-saving solutions for our customers and, in so doing, become a global leader in the sensor and medical device fields. For more information please visit our web site at: http://www.apogeemems.com .

PyraDerm™ and Sensilica® are trademarks of Apogee Technology, Inc. All other product names noted herein may be trademarks of their respective holders. Certain statements made herein that use the words "anticipate," "hope," "estimate," "project," "will," "intend," "plan," "expect," "believe" and similar expressions are intended to identify forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements involve known and unknown risks and uncertainties, which could cause the actual results, performance or achievements of the Company to be materially different from those that may be expressed or implied. Please refer to the company's risk factors as set forth in the Company's filings with the Securities and Exchange Commission, including its reports on Forms 10-KSB and 10-QSB.

For more information, please click here

Contacts:
Kelly Black
Premier Funding & Financial Marketing
480-649-8224

Copyright © Market Wire

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

Sensors

Detection of Heavy Metals in Samples with Naked Eye January 26th, 2015

GS7 Graphene Sensor maybe Solution in Fight Against Cancer January 25th, 2015

Nanosensor Used for Simultaneous Determination of Effective Tea Components January 24th, 2015

Iranian Scientists Produce Graphene-Based Oxygen Sensor January 23rd, 2015

Announcements

Advantest to Exhibit at SEMICON Korea in Seoul, South Korea February 4-6 Showcasing Broad Portfolio of Semiconductor Products, Technologies and Solutions January 29th, 2015

Park Systems Announces Innovations in Bio Cell Analysis with the Launch of Park NX-Bio, the only 3-in-1 Imaging Nanoscale Tool Available for Life Science Researchers January 29th, 2015

2015 Nanonics Image Contest January 29th, 2015

Iranian Scientists Use MOFs to Eliminate Dye Pollutants January 29th, 2015

Appointments/Promotions/New hires/Resignations/Deaths

Nexeon Board Changes Announced January 29th, 2015

Rice's Naomi Halas to direct Smalley Institute: Optics pioneer will lead Rice's multidisciplinary science institute January 15th, 2015

SUNY Board Appoints Dr. Alain Kaloyeros as Founding President of SUNY Polytechnic Institute January 13th, 2015

Blend Therapeutics Appoints Distinguished Physician Scientist, Dennis Ausiello, MD, to Board of Directors January 8th, 2015

NanoNews-Digest
The latest news from around the world, FREE



  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoTech-Transfer
University Technology Transfer & Patents
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More










ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project







© Copyright 1999-2015 7th Wave, Inc. All Rights Reserved PRIVACY POLICY :: CONTACT US :: STATS :: SITE MAP :: ADVERTISE